Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1988 1
1990 2
1991 3
1992 1
1993 4
1994 7
1995 3
1996 8
1997 2
1998 9
1999 7
2000 4
2001 4
2002 9
2003 5
2004 9
2005 9
2006 8
2007 12
2008 12
2009 18
2010 15
2011 23
2012 15
2013 5
2014 1
2015 5
2016 7
2017 1
2018 1
2019 5
2020 9
2021 6
2022 2
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma.
Sklavenitis-Pistofidis R, Aranha MP, Redd RA, Baginska J, Haradhvala NJ, Hallisey M, Dutta AK, Savell A, Varmeh S, Heilpern-Mallory D, Ujwary S, Zavidij O, Aguet F, Su NK, Lightbody ED, Bustoros M, Tahri S, Mouhieddine TH, Wu T, Flechon L, Anand S, Rosenblatt JM, Zonder J, Vredenburgh JJ, Boruchov A, Bhutani M, Usmani SZ, Matous J, Yee AJ, Jakubowiak A, Laubach J, Manier S, Nadeem O, Richardson P, Badros AZ, Mateos MV, Trippa L, Getz G, Ghobrial IM. Sklavenitis-Pistofidis R, et al. Among authors: vredenburgh jj. Cancer Cell. 2022 Nov 14;40(11):1358-1373.e8. doi: 10.1016/j.ccell.2022.10.017. Cancer Cell. 2022. PMID: 36379208 Free PMC article.
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T. Friedman HS, et al. Among authors: vredenburgh j. J Clin Oncol. 2009 Oct 1;27(28):4733-40. doi: 10.1200/JCO.2008.19.8721. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720927 Clinical Trial.
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WKA, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T. Friedman HS, et al. Among authors: vredenburgh j. J Clin Oncol. 2023 Nov 10;41(32):4945-4952. doi: 10.1200/JCO.22.02772. J Clin Oncol. 2023. PMID: 37935104 Clinical Trial.
Neurofibromatosis type 2.
Sathornsumetee S, DesJardins A, Reardon DA, Rich JN, Vredenburgh JJ. Sathornsumetee S, et al. Among authors: vredenburgh jj. Neurology. 2007 Mar 27;68(13):E14. doi: 10.1212/01.wnl.0000257828.56178.9f. Neurology. 2007. PMID: 17389295 No abstract available.
Chordoma: A Case Report and Review of Literature.
Noor A, Bindal P, Ramirez M, Vredenburgh J. Noor A, et al. Among authors: vredenburgh j. Am J Case Rep. 2020 Jan 23;21:e918927. doi: 10.12659/AJCR.918927. Am J Case Rep. 2020. PMID: 31969553 Free PMC article. Review.
Molecularly targeted therapy for malignant glioma.
Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN. Sathornsumetee S, et al. Among authors: vredenburgh jj. Cancer. 2007 Jul 1;110(1):13-24. doi: 10.1002/cncr.22741. Cancer. 2007. PMID: 17520692 Free article. Review.
Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.
Reardon DA, Wen PY, Desjardins A, Batchelor TT, Vredenburgh JJ. Reardon DA, et al. Among authors: vredenburgh jj. Expert Opin Biol Ther. 2008 Apr;8(4):541-53. doi: 10.1517/14712598.8.4.541. Expert Opin Biol Ther. 2008. PMID: 18352856 Free PMC article. Review.
211 results